The intervention group showed favourable changes in psychometric tests and plasma biomarkers, but the exploratory sample does not support definitive conclusions.
The collection shows why mechanisms, composition, preclinical models and clinical work must converge before a natural signal becomes a robust product rationale.
The trend does not replace individual-ingredient rationale; it adds the need to measure absorption, interactions, adherence and outcomes for the marketed formula.
Finished-formula validation needs a sequence: identity and stability, exposure, nutritional-status change, functional outcomes and comparison with simpler alternatives.
The conceptual model moves from predicting the properties of a recipe to generating combinations compatible with technical constraints and multiple objectives.
The caffeine-free botanical complex is positioned for energy, focus and mood applications, with dsm-firmenich supporting clinical, regulatory and commercial development.
The trial reported fewer episodes and a lower overall burden, particularly among recurrent cases, but no significant difference in time to first infection.
The project combines nutrivigilance, reports and botanical screening to identify priorities for further investigation, not an automatic list of prohibited ingredients.
Combining diet, biomarkers, multi-omics, microbiome and wearables is not enough: models must generalise and show value in real populations and settings.
Age, education, urbanisation and dietary composition change the footprint of diets; targeted interventions may be more informative than uniform approaches.